Does Dr. MALAZ ALATASSI have financial conflicts of interest?

Dr. MALAZ ALATASSI (M.D.) has received a total of $549 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $549 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MALAZ ALATASSI?

According to CMS Open Payments data, Dr. MALAZ ALATASSI received funding from OTSUKA AMERICA PHARMACEUTICAL ($85), NOVO NORDISK ($74), and AMGEN ($58).

Does Dr. MALAZ ALATASSI receive research grants or speaking fees?

Dr. MALAZ ALATASSI has received $549 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MALAZ ALATASSI

M.D.Real-Time Hydrated

Specialty: Internal Medicine

Practice Location: SHELBY TOWNSHIP, MI 48315

NPI Number: 1023069770

LIFETIME INDUSTRY VALUE

$549

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ALATASSI is a verified Internal Medicine practitioner based in SHELBY TOWNSHIP, MI.

Between 2021 and 2025, Dr. ALATASSI had an overall industry promotional and research financial footprint of $549 as recorded in the federal CMS Open Payments database.

$549 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALATASSI's primary funding source is OTSUKA AMERICA PHARMACEUTICAL, which accounts for $85 (representing 15.5% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

OTSUKA AMERICA PHARMACEUTICAL

Rank 1

$85

15.5%

NOVO NORDISK

Rank 2

$74

13.4%

AMGEN

Rank 3

$58

10.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.